Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT...
The HIV pandemic continues to impose enormous morbidity, mortality and economic burdens across the g...
There are scarce data regarding influenza vaccination among people with HIV infection (PWHIV). The g...
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity and mortality ...
There is no correlation between HIV per se and other risk factors for severe COVID-19 disease. Pivot...
International audienceBACKGROUND: Several vaccines are recommended in HIV-infected patients due to a...
The administration of COVID-19 vaccines is the primary strategy used to prevent further infections b...
BackgroundUnderstanding the spectrum of COVID-19 in people with HIV (PWH) is critical to provide cli...
BACKGROUND: COVID-19, a novel respiratory illness caused by SARS-CoV-2, has become a global pandemic...
Background. Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minor...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus dis...
International audienceBACKGROUND: A mass influenza A/H1N1 vaccination campaign took place in France ...
Introduction: People living with HIV (PLWH) are at higher risk of poorer COVID-19 outcomes. Vaccinat...
The quest for a safe and effective HIV vaccine holds life-saving potential for people globally. Inte...
United States guidelines recommend hepatitis A virus (HAV) vaccination for persons living with HIV (...
Background: To date there remains much ambiguity in the literature regarding the immunological inter...
The HIV pandemic continues to impose enormous morbidity, mortality and economic burdens across the g...
There are scarce data regarding influenza vaccination among people with HIV infection (PWHIV). The g...
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity and mortality ...
There is no correlation between HIV per se and other risk factors for severe COVID-19 disease. Pivot...
International audienceBACKGROUND: Several vaccines are recommended in HIV-infected patients due to a...
The administration of COVID-19 vaccines is the primary strategy used to prevent further infections b...
BackgroundUnderstanding the spectrum of COVID-19 in people with HIV (PWH) is critical to provide cli...
BACKGROUND: COVID-19, a novel respiratory illness caused by SARS-CoV-2, has become a global pandemic...
Background. Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minor...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus dis...
International audienceBACKGROUND: A mass influenza A/H1N1 vaccination campaign took place in France ...
Introduction: People living with HIV (PLWH) are at higher risk of poorer COVID-19 outcomes. Vaccinat...
The quest for a safe and effective HIV vaccine holds life-saving potential for people globally. Inte...
United States guidelines recommend hepatitis A virus (HAV) vaccination for persons living with HIV (...
Background: To date there remains much ambiguity in the literature regarding the immunological inter...
The HIV pandemic continues to impose enormous morbidity, mortality and economic burdens across the g...
There are scarce data regarding influenza vaccination among people with HIV infection (PWHIV). The g...
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity and mortality ...